| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |